UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro

Breast cancer research : BCR, 2009-01, Vol.11 (5), p.R77-R77, Article R77

2009

Volltextzugriff (PDF)

Dacomitinib (PF-00299804), an irreversible Pan-HER inhibitor, inhibits proliferation of HER2-amplified breast cancer cell lines resistant to trastuzumab and lapatinib

Molecular cancer therapeutics, 2012-09, Vol.11 (9), p.1978-1987

2012

Volltextzugriff (PDF)

In vitro activity of the mTOR inhibitor everolimus, in a large panel of breast cancer cell lines and analysis for predictors of response

Breast cancer research and treatment, 2015-02, Vol.149 (3), p.669-680

2015

Volltextzugriff (PDF)

The HSP90 inhibitor NVP-AUY922 potently inhibits non-small cell lung cancer growth

Molecular cancer therapeutics, 2013-06, Vol.12 (6), p.890-900

2013

Volltextzugriff (PDF)

Antiestrogen Fulvestrant Enhances the Antiproliferative Effects of Epidermal Growth Factor Receptor Inhibitors in Human Non–Small-Cell Lung Cancer

Journal of thoracic oncology, 2013-03, Vol.8 (3), p.270-278

2013

Volltextzugriff (PDF)

Lapatinib, a Dual EGFR and HER2 Kinase Inhibitor, Selectively Inhibits HER2-Amplified Human Gastric Cancer Cells and is Synergistic with Trastuzumab In vitro and In vivo

Clinical cancer research, 2010-03, Vol.16 (5), p.1509-1519

2010

Volltextzugriff (PDF)

PD-0332991, a potent and selective inhibitor of cyclin-dependent kinase 4/6, demonstrates inhibition of proliferation in renal cell carcinoma at nanomolar concentrations and molecular markers predict for sensitivity

Anticancer research, 2013-08, Vol.33 (8), p.2997-3004

2013

Volltextzugriff (PDF)

Inhibition of HSP90 with AUY922 induces synergy in HER2-amplified trastuzumab-resistant breast and gastric cancer

Molecular cancer therapeutics, 2013-04, Vol.12 (4), p.509-519

2013

Volltextzugriff (PDF)

AMG 900, pan-Aurora kinase inhibitor, preferentially inhibits the proliferation of breast cancer cell lines with dysfunctional p53

Breast cancer research and treatment, 2013-10, Vol.141 (3), p.397-408

2013

Volltextzugriff (PDF)

Effect of PD-0332991, a potent and selective inhibitor of cyclin-dependent kinase 4/6, on proliferation in renal cell carcinoma at nanomolar concentrations and prediction of sensitivity by molecular markers

Journal of clinical oncology, 2013-02, Vol.31 (6_suppl), p.413-413

2013

Volltextzugriff (PDF)

Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients

The New England journal of medicine, 2019-04, Vol.380 (17), p.1606-1617

2019

Volltextzugriff (PDF)

Digital Single-operator Cholangioscopy (DSOC) Improves Interobserver Agreement (IOA) and Accuracy for Evaluation of Indeterminate Biliary Strictures: The Monaco Classification

Journal of clinical gastroenterology, 2022-02, Vol.56 (2), p.e94-e97

2022

Volltextzugriff (PDF)

Radiation Therapy Administration and Survival in Stage I/II Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue

International journal of radiation oncology, biology, physics, 2014-03, Vol.88 (3), p.642-649

2014

Volltextzugriff (PDF)

Adult lymphoma-associated hemophagocytic lymphohistiocytosis: A clinical case series in a predominantly Hispanic cohort from the University of Miami/Jackson Memorial Hospital

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e20060-e20060

2020

Volltextzugriff (PDF)

Evaluation of the physician-patient communication assessment tool (CAT) in a hematology-oncology practice

Journal of clinical oncology, 2013-11, Vol.31 (31_suppl), p.14-14

2013

Volltextzugriff (PDF)

Laboratory surveillance for SARS-CoV-2 in India: Performance of testing & descriptive epidemiology of detected COVID-19, January 22 - April 30, 2020

Indian journal of medical research (New Delhi, India : 1994), 2020-05, Vol.151 (5), p.424-437

2020

Volltextzugriff (PDF)

Radiotherapy in Stage I and II Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT): Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database

Blood, 2012-11, Vol.120 (21), p.2053-2053

2012

Volltextzugriff (PDF)

Using the COVID-19 pandemic to reimagine global health teaching in high-income countries

BMJ global health, 2021-04, Vol.6 (4), p.e005649

2021

Volltextzugriff (PDF)

Outcome of Patients Undergoing Hematopoietic Cell Transplantation for TP53-Mutated Acute Leukemias and MDS: Effect of Conditioning and GvHD Prophylaxis Regimens Intensity

Blood, 2022-11, Vol.140 (Supplement 1), p.10624-10626

2022

Volltextzugriff (PDF)

Identification of common predictive markers of in vitro response to the Mek inhibitor selumetinib (AZD6244; ARRY-142886) in human breast cancer and non-small cell lung cancer cell lines

Molecular cancer therapeutics, 2010-07, Vol.9 (7), p.1985-1994

2010

Volltextzugriff (PDF)

Impact of spliceosome mutation on outcomes of myelodysplastic syndrome and chronic myelomonocytic leukemia patients undergoing allogeneic hematopoietic cell transplantation

Leukemia research, 2024-10, Vol.145, p.107565, Article 107565

2024

Volltextzugriff (PDF)

Maintenance rituximab or observation after frontline treatment with bendamustine‐rituximab for follicular lymphoma

British journal of haematology, 2019-02, Vol.184 (4), p.524-535

2019

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(52)
Berichte
(1)

Sprache

Englisch
(53)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Humans
(22)
Female
(13)
Oncology
(13)
Cell Proliferation - Drug Effects
(10)
Aged
(9)
Cell Line, Tumor
(9)
Male
(9)
Apoptosis - Drug Effects
(8)
Middle Aged
(8)
Adult
(6)
Cell Cycle - Drug Effects
(6)
Gastroenterology And Hepatology
(5)
Gene Expression Regulation, Neoplastic - Drug Effects
(5)
Receptor, Erbb-2 - Genetics
(5)
Trastuzumab
(5)
Age Factors
(4)
Breast Neoplasms - Genetics
(4)
Breast Neoplasms - Pathology
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro

Dacomitinib (PF-00299804), an irreversible Pan-HER inhibitor, inhibits proliferation of HER2-amplified breast cancer cell lines resistant to trastuzumab and lapatinib

In vitro activity of the mTOR inhibitor everolimus, in a large panel of breast cancer cell lines and analysis for predictors of response

The HSP90 inhibitor NVP-AUY922 potently inhibits non-small cell lung cancer growth

Antiestrogen Fulvestrant Enhances the Antiproliferative Effects of Epidermal Growth Factor Receptor Inhibitors in Human Non–Small-Cell Lung Cancer

Lapatinib, a Dual EGFR and HER2 Kinase Inhibitor, Selectively Inhibits HER2-Amplified Human Gastric Cancer Cells and is Synergistic with Trastuzumab In vitro and In vivo

PD-0332991, a potent and selective inhibitor of cyclin-dependent kinase 4/6, demonstrates inhibition of proliferation in renal cell carcinoma at nanomolar concentrations and molecular markers predict for sensitivity

Inhibition of HSP90 with AUY922 induces synergy in HER2-amplified trastuzumab-resistant breast and gastric cancer

AMG 900, pan-Aurora kinase inhibitor, preferentially inhibits the proliferation of breast cancer cell lines with dysfunctional p53

Effect of PD-0332991, a potent and selective inhibitor of cyclin-dependent kinase 4/6, on proliferation in renal cell carcinoma at nanomolar concentrations and prediction of sensitivity by molecular markers

Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients

Endoscopic Therapy With Lumen-apposing Metal Stents Is Safe and Effective for Patients With Pancreatic Walled-off Necrosis

Digital Single-operator Cholangioscopy (DSOC) Improves Interobserver Agreement (IOA) and Accuracy for Evaluation of Indeterminate Biliary Strictures: The Monaco Classification

Radiation Therapy Administration and Survival in Stage I/II Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue

Adult lymphoma-associated hemophagocytic lymphohistiocytosis: A clinical case series in a predominantly Hispanic cohort from the University of Miami/Jackson Memorial Hospital

Evaluation of the physician-patient communication assessment tool (CAT) in a hematology-oncology practice

Laboratory surveillance for SARS-CoV-2 in India: Performance of testing & descriptive epidemiology of detected COVID-19, January 22 - April 30, 2020

Radiotherapy in Stage I and II Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT): Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database

Using the COVID-19 pandemic to reimagine global health teaching in high-income countries

Fractionated Total Body Irradiation and Fludarabine Based Conditioning Regimen with Post-Transplant Cyclophosphamide (PTCy) for Mismatched Related and Unrelated Donors HCT for Acute Leukemia and MDS

Outcome of Patients Undergoing Hematopoietic Cell Transplantation for TP53-Mutated Acute Leukemias and MDS: Effect of Conditioning and GvHD Prophylaxis Regimens Intensity

Identification of common predictive markers of in vitro response to the Mek inhibitor selumetinib (AZD6244; ARRY-142886) in human breast cancer and non-small cell lung cancer cell lines

Sirolimus Results in Similar Outcomes to Tacrolimus for Gvhd Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide

Impact of spliceosome mutation on outcomes of myelodysplastic syndrome and chronic myelomonocytic leukemia patients undergoing allogeneic hematopoietic cell transplantation

Maintenance rituximab or observation after frontline treatment with bendamustine‐rituximab for follicular lymphoma

Suchergebnisse filtern